Johanna Risse
YOU?
Author Swipe
View article: “Snip, snip, cure”? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies
“Snip, snip, cure”? Philosophical, legal and biomedical perspectives on novel somatic genomic therapies Open
The advent of innovative techniques, such as the CRISPR/Cas system, has opened up a new range of possibilities for modifying the genome, with the potential to address previously unmet therapeutic needs of patients with genetic diseases. Th…
View article: Towards ethical drug pricing: the European Orphan Genomic Therapies Fund
Towards ethical drug pricing: the European Orphan Genomic Therapies Fund Open
An increasing number of novel genomic therapies are expected to become available for patients with rare or ultra-rare diseases. However, the primary obstacle to equal patient access to these orphan genomic therapies are currently very high…